Covered recipient · General Payments record
EMILY DRURY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021
$273.17
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $201.57 | 15 |
| Education | $71.60 | 2 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $127.17 | 12 |
| ITI, Inc. | $82.69 | 3 |
| Neurocrine BioSciences, Inc. | $46.89 | 1 |
| Otsuka America Pharmaceutical, Inc. | $16.42 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2021 | $273.17 | 17 |
Payment records · PY2021 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $4.11 | 02/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796459561 | CMS |
| AbbVie Inc. | $10.02 | 03/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796459563 | CMS |
| AbbVie Inc. | $4.89 | 04/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796459565 | CMS |
| AbbVie Inc. | $13.70 | 04/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796459567 | CMS |
| AbbVie Inc. | $13.18 | 05/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796459569 | CMS |
| AbbVie Inc. | $14.61 | 06/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796459571 | CMS |
| AbbVie Inc. | $14.32 | 07/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796459573 | CMS |
| AbbVie Inc. | $13.18 | 08/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796459575 | CMS |
| AbbVie Inc. | $13.26 | 08/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796459577 | CMS |
| AbbVie Inc. | $2.75 | 09/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796459579 | CMS |
| AbbVie Inc. | $8.07 | 09/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796459581 | CMS |
| AbbVie Inc. | $15.08 | 11/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796459583 | CMS |
| ITI, Inc. | $24.69 | 02/24/2021 | Education | Undisputed | 01/23/2026 | 830215025 | CMS |
| ITI, Inc. | $46.91 | 10/20/2021 | Education | Undisputed | 01/23/2026 | 830215031 | CMS |
| ITI, Inc. | $11.09 | 10/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | 830215037 | CMS |
| Neurocrine Biosciences, Inc. | $46.89 | 11/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 837830141 | CMS |
| Otsuka America Pharmaceutical, Inc. | $16.42 | 01/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 834815603 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021
- Source files
- Dataset page · Bulk file · PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.